The MIT Startup Exchange is looking for 3-4 MIT startups to present and exhibit at the MIT ILP one-day Taiwan symposium (Taipei, Taiwan; Wednesday July 17, 2019). Each selected startup will present a short lightning talk on a technology-based product they are bringing to market, including at least one compelling use case. All presenting startups are expected to exhibit as well.
The 2023 MIT Japan Conference will feature future trends of research at MIT and highlight advances in key areas, including advanced materials, healthcare technologies, infrastructure, energy, and management. Attendees will have the opportunity for continued in-depth discussions with faculty speakers and MIT Startup Exchange startups during both lunch and an evening networking reception.
Please visit the MIT ILP site for the full agenda.
The 2024 MIT Japan Conference will feature future trends of research at MIT and highlight advances in key areas, including autonomous vehicle navigation, chemical engineering, the Chinese economy, energy storage and conversion, healthcare technologies, and materials science.
Rio Tinto seeks opportunities to implement emerging technologies to support efforts to decarbonise their rail network.
In this energy-focused webinar, we invited two world-leading researchers in this domain from MIT, Emre Gençer and Jennifer Morris, to discuss two important topics: Industrial decarbonization, and the interplay between carbon dioxide removal and carbon trading systems.
In this computationally-assisted materials webinar, Attendees will gain insights into advanced algorithms, data-driven approaches, and the future of automated material synthesis. From optimizing material properties to scaling innovation, this session will showcase the practical benefits of computational research.
Hear from distinguished MIT faculty and startups on topics such as recent advances in precision medicine for a more targeted and personalized treatment, immunotherapy to fight cancer cells, gene therapy, AI to improve diagnosis, treatment, and patient outcomes, and more.